indocyanine green has been researched along with Central Serous Chorioretinopathy in 192 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (0.52) | 29.6817 |
2010's | 146 (76.04) | 24.3611 |
2020's | 45 (23.44) | 2.80 |
Authors | Studies |
---|---|
Boon, CJF; Haarman, AEG; Kaden, TR; Klaver, CCW; Ravenstijn, M; van Dijk, EHC; Vermeer, KA; Yannuzzi, LA; Yzer, S | 1 |
Blanco-Garavito, R; Boon, CJF; Breukink, MB; Downes, SM; Fauser, S; Hahn, LC; Hoyng, CB; Keunen, JEE; MacLaren, RE; Querques, G; Scholz, P; Souied, EH; Tsonaka, R; van Dijk, EHC; van Rijssen, TJ | 1 |
Amoroso, F; Astroz, P; Capuano, V; Chhablani, J; Cohen, SY; Colantuono, D; Jung, C; Miere, A; Pedinielli, A; Semoun, O; Souied, EH | 1 |
Jeong, S; Kang, W; Noh, D; Sagong, M; van Hemert, J | 1 |
Akhlaghi, M; Baghi, A; Dehghani, A; Fazel, F; Ghanbari, H; Kianersi, F; Masjedi, M; Pourazizi, M; Razmjoo, H; Salehi, A | 1 |
Barbazetto, I; Ngo, WK; Sorenson, JA; Spaide, RF | 1 |
Fukuda, Y; Fukui, A; Kashiwagi, K; Kikushima, W; Kusada, N; Mabuchi, F; Matsubara, M; Parikh, R; Sakurada, Y; Shijo, T; Sotozono, C; Sugiyama, A; Terao, N; Yoneyama, S | 1 |
Azuma, K; Fujino, R; Hashimoto, Y; Inoue, T; Kitamoto, K; Nomura, Y; Obata, R; Ueda, K | 1 |
Li, S; Qu, J; Yang, Z; Yao, Y; Zeng, Q; Zhao, M | 1 |
Chen, M; Chen, T; Long, P; Yan, W; Zhang, L; Zhang, Z | 1 |
Cabral, D; Freund, KB; Galhoz, D; Oh, D; Ramtohul, P | 1 |
Bandello, F; Battista, M; Borrelli, E; Grosso, D; Querques, G; Querques, L; Sacconi, R; Senni, C; Viganò, C | 1 |
Ebrahimiadib, N; Esfandiarifard, S; Fadakar, K; Imani Fooladi, M; Mirzaei, A; Najibzadeh, E; Tuli, S | 1 |
Aksu Ceylan, N; Cebeci, Z | 1 |
Behar-Cohen, F; Bousquet, E; Favard, C; Gigon, A; Mantel, I; Zola, M | 1 |
Behera, UC; Brar, AS; Lakhmawar, PK | 1 |
Al-Khuzaei, S; Bird, AC; Chadha, R; Chong, V; Downes, SM; Gibson, A; Mall, SP | 1 |
Chen, X; Gan, Y; He, G; Li, M; Su, Y; Wen, F; Zeng, Y; Zhang, X; Zhuang, X | 1 |
Araki, T; Fukuyama, H; Gomi, F; Kanda, H; Okita, Y; Sugisawa, T; Yamamoto, Y; Zhou, X | 1 |
Chhablani, J; Dhurandhar, DS; Goud, A; Lupidi, M; Sahoo, NK; Singh, SR | 1 |
Chae, JB; Hwang, H; Kim, DY; Kim, JY; Kim, KT | 1 |
Freund, KB; Leong, BCS; Sadda, SR; Sarraf, D; Teke, MY; Yu, HG; Yzer, S; Zatreanu, L | 1 |
Behar-Cohen, F; Daruich, A; Elalouf, M; Mantel, I; Matet, A; Romdhane, K; Zola, M | 1 |
Boon, CJF; Hoyng, CB; Mohabati, D; Yzer, S | 1 |
Kang, MS; Kim, ES; Kim, K; Noh, SR; Yu, SY | 1 |
Baek, J; Hong, SW; Kang, NY; Kim, EC; Kwak, JH; Ra, H | 1 |
Bandello, F; Battista, M; Borrelli, E; De Geronimo, D; Gelormini, F; Parravano, M; Querques, G; Querques, L; Sacconi, R; Tedeschi, M | 1 |
Arrigo, A; Bandello, F; Battaglia Parodi, M; Introini, U; Jampol, LM; Mercuri, S; Rajabian, F | 1 |
Arcos-Villegas, G; Arias-Barquet, L; Duker, JS; Flores-Moreno, I; Ruiz-Medrano, J; Ruiz-Moreno, JM; Sastre, M | 1 |
Chen, SN; Chen, YC | 1 |
Hagenau, F; Herold, T; Keidel, LF; Kern, C; Kortuem, KU; Luft, N; Priglinger, SG; Schworm, B; Siedlecki, J | 1 |
Boon, CJF; Chhablani, J; Rasheed, MA; Singh, SR; van Dijk, EHC; van Rijssen, TJ; Vupparaboina, KK | 1 |
Albanese, M; Barbano, L; De Geronimo, D; Giorno, P; Landi, D; Marfia, GA; Parisi, V; Parravano, M; Ziccardi, L | 1 |
Lin, W; Liu, T; Meng, X; Zhou, S | 1 |
Boon, CJF; Breukink, MB; Dijkman, G; Downes, SM; Fauser, S; Hoyng, CB; MacLaren, RE; Peters, PJH; Scholz, P; Tsonaka, R; van Dijk, EHC; van Rijssen, TJ | 1 |
Jain, K; Pereira, A; Venkatesh, R; Yadav, NK | 1 |
Hoang, QV; Ito, K; Jung, JJ; Lee, SS; Rofagha, S; Yu, DJG | 1 |
Hayashida, M; Honda, S; Imai, H; Kusuhara, S; Matsumiya, W; Miki, A; Nakai, S; Nakamura, M | 1 |
Hayashida, M; Honda, S; Miki, A; Nakamura, M | 1 |
Ding, X; Gong, Y; Huang, C; Jin, C; Lai, K; Li, L; Lian, P; Lu, L; Xu, F; Zhou, L | 1 |
Bandello, F; Battista, M; Borrelli, E; Gelormini, F; Grosso, D; Querques, G; Querques, L; Sacconi, R; Vella, G | 1 |
Beka, S; Bolz, M; de Sisternes, L; Foessl, B; Mursch-Edlmayr, AS; Podkowinski, D; Strauss, RW | 1 |
Agrawal, R; Barathi, VA; Busoy, JM; Chakravarthy, U; Cheong, KX; Cheung, CMG; Ho, CEH; Takahashi, K; Teo, KYC; Tun, SBB | 1 |
Azzolini, C; Cattaneo, J; Chiaravalli, M; Donati, S; Metrangolo, C; Premoli, L | 1 |
Bonnin, S; Boulanger, E; Delahaye-Mazza, C; Gaudric, A; Tadayoni, R | 1 |
Brelén, ME; Chen, H; Chen, LJ; Ho, M; Lai, TYY; Mohamed, S; Ng, DS; Pang, CP; Teh, WM; Tsang, CW; Yip, FL; Zhou, L | 1 |
Gomi, F; Hozumi, K; Iwahashi, C; Komuku, Y; Mitarai, K; Tanaka, C | 1 |
Manayath, GJ; Narendran, V; Saravanan, VR; Shah, VS | 1 |
Fernandes, L; Jorge, R; Leão, PMS; Ribeiro, J; Siqueira, R; Viana, KÍS | 1 |
Chhablani, J; Kulikov, AN; Maltsev, DS | 1 |
Baldin, G; Bandello, F; Carnevali, A; Marchini, G; Querques, G; Querques, L; Rabiolo, A; Sacconi, R | 1 |
Alkin, Z; Demircan, A; Yesilkaya, C | 1 |
Arevalo, JF; Berrocal, MH; Chhablani, J; Fromow-Guerra, J; Gallego-Pinazo, R; Lima, LH; Lozano-Rechy, D; Roca, JA; Rodríguez, FJ; Rojas, S; Serrano, M; Wu, L | 1 |
Chan, YY; Chung, CY; Li, KKW | 1 |
Gong, YY; Lv, Y; Min, JY; Yu, S | 1 |
Hirooka, K; Kobayashi, M; Ono, A; Osaka, R; Shiragami, C; Takasago, Y; Yamashita, A | 1 |
Ayachit, A; Ayachit, G; Kumar, V; Raj, N | 1 |
Mishra, C | 1 |
Chi, YK; Han, JW; Kim, KW; Kim, YK; Park, KH; Woo, SJ | 1 |
Purtskhvanidze, K; Roider, J; Sheptulin, V | 1 |
Fragiotta, S; Freund, KB; Leong, BCS; Parikh, R; Sakurada, Y | 1 |
Altay, L; Boon, CJF; De Jong, EK; Fauser, S; Hoyng, CB; Mohabati, D; Schellevis, RL; van Dijk, EHC; Yzer, S | 1 |
Akiyama, H; Hiroe, T; Kishi, S; Matsumoto, H; Sakamoto, T; Sonoda, S | 1 |
Seo, EJ; Um, T; Yoon, YH | 1 |
Balaratnasingam, C; Bhavsar, KV; Bottini, A; Chen, KC; Dansingani, K; Freund, KB; Kaden, TR; Mrejen, S; Patel, S; Spaide, RF; Stoffels, G; Yannuzzi, LA; Yannuzzi, NA; Yu, S | 1 |
Hu, J; Li, M; Piao, Z; Qu, J; Sun, G; Yao, Y; Zhao, M | 1 |
Mantel, I; Romdhane, K | 1 |
Hosoda, Y; Khor, CC; Miyake, M; Miyata, M; Oishi, A; Ooto, S; Tsujikawa, A; Uji, A; Wong, TY; Yamashiro, K | 1 |
Azad, SV; Daga, D; Kumar, V | 1 |
Chhablani, J; Gupta, R | 1 |
Chang, W; Lim, SH; Sagong, M | 1 |
Jonas, JB; Wei, WB; Yang, LH | 2 |
Akagi-Kurashige, Y; Arichika, S; Ellabban, AA; Miyake, M; Nakata, I; Oishi, A; Ooto, S; Takahashi, A; Tsujikawa, A; Ueda-Arakawa, N; Yamashiro, K; Yoshimura, N; Yoshitake, S | 1 |
Freund, KB; Mrejen, S; Mukkamala, SK; Sarraf, D | 1 |
Atmani, K; Benhamou, N; Querques, G; Souied, EH; Zourdani, A | 1 |
Akova-Budak, B; Gelisken, O; Gorkem Cevik, S; Ozkaya, G; Yalcinbayir, O; Yucel, AA | 1 |
Boon, CJ; Freund, KB; Jung, J; Mrejen, S; Yannuzzi, LA | 1 |
Bae, SH; Chung, H; Heo, J; Kim, C; Kim, TW; Lee, JY; Moon, SW; Park, TK; Shin, JY; Song, SJ | 1 |
Adhi, M; Baumal, C; Duker, JS; Ferrara, D; Fujimoto, JG; Grulkowski, I; Hornegger, J; Kraus, MF; Liu, JJ; Mohler, KJ; Waheed, N | 1 |
Cavallero, E; Querques, G; Razavi, S; Souied, EH; Weber, M | 1 |
Hwang, DJ; Kang, HM; Kim, H; Kim, YK; Lee, CS; Lee, SC; Woo, SJ | 1 |
Agca, A; Alkin, Z; Demirok, A; Ozkaya, A; Yazici, AT | 1 |
Chan, D; Egan, CA; Errera, MH; Keane, PA; Michaelides, M; Moore, AT; Paques, M; Patel, PJ; Restori, M; Tufail, A; Yeoh, J | 1 |
Alovisi, C; Cardillo Piccolino, F; Eandi, CM; Grignolo, FM; Musetti, D; Nicoló, M; Traverso, CE | 1 |
De Salvo, G; Keane, PA; Sarraf, D; Tufail, A | 1 |
Freund, KB; Pang, CE; Sarraf, D; Shah, VP | 1 |
Kawamura, A; Mori, R; Shinojima, A; Yuzawa, M | 1 |
Kiss, S; Nudleman, E; Williams, GA; Witmer, MT; Wolfe, JD | 1 |
Chan, CM; Cheung, CM; Lim, FP; Lim, LS; Loh, BK; Wong, DW | 1 |
Ma, J; Meng, N; Qu, Y; Xu, X; Zhou, F | 1 |
Chung, HW; Huh, K; Kim, JT; Kim, SW; Oh, J; Yun, CM | 1 |
Ansari-Shahrezaei, S; Binder, S; Glittenberg, C; Hagen, S; Krebs, I; Smretschnig, E; Steiner, I | 1 |
Kim, BH; Park, KH; Park, SJ; Woo, SJ | 1 |
Karska-Basta, I; Kolár, L; Oleksy, P; Pociej, W; Romanowska-Dixon, B | 1 |
Lavinsky, D; Palanker, D | 1 |
Freund, KB; Pang, CE | 1 |
Hamzah, F; Mori, R; Shinojima, A; Yuzawa, M | 1 |
Bakker, B; Boon, CJ; Breukink, MB; de Jong, EK; den Hollander, AI; Fauser, S; Hoyng, CB; Keunen, JE; Mohr, JK; Schellevis, RL | 1 |
Fujita, K; Hashizume, K; Imamura, Y; Matsumoto, CS; Mizota, A; Mizutani, Y; Shinoda, K; Yuzawa, M | 1 |
Broadhead, GK; Chang, A | 1 |
Chen, Y; Dai, H; Dong, C; Jiao, X; Kang, X; Li, X; Li, Y; Liu, P; Liu, Y; Lu, Y; Pan, CT; Qu, J; Tian, R; Xiong, Y; Yang, L; Yu, X; Zhang, F; Zhang, L; Zhao, M; Zhou, H; Zhou, P | 1 |
Matsuura, T; Ogata, N; Okamoto, M | 1 |
Hirooka, K; Izumibata, S; Manabe, S; Shiraga, F; Shiragami, C; Tsujikawa, A | 1 |
Baddar, D; Fawzi, AA; Jampol, LM; Munk, MR; Pappas, F; Shah, R; Wong, B | 1 |
Battu, R; Dabir, S; Jayadev, C; Mohan, A; Shetty, B; Shetty, R; Vijayan, P; Yadav, NK | 1 |
Huh, K; Kim, HJ; Kim, JT; Kim, SW; Nam, KT; Oh, J; Yang, KS; Yun, CM | 1 |
Gaudric, A; Hage, R; Krivosic, V; Mrejen, S; Quentel, G; Tadayoni, R | 1 |
Fok, AC; Lai, TY; Lee, A; Liu, AT; Luk, FO | 1 |
Carpineto, P; Di Antonio, L; Di Iorio, A; Mastropasqua, A; Mastropasqua, L; Toto, L | 1 |
Kim, YK; Park, KH; Ryoo, NK; Woo, SJ | 1 |
Caminiti, G; Ferrara, DC; Hughes, J; Mura, M; Peiretti, E | 1 |
Eandi, CM; El Maftouhi, A; Quaranta-El Maftouhi, M | 1 |
Boon, CJ; Breukink, MB; de Jong, EK; Hoyng, CB; Klevering, BJ; Teussink, MM; Theelen, T; van Grinsven, MJ | 1 |
Guo, L; Hua, R; Li, J; Tao, J; Xia, F; Yang, G; Yao, K | 1 |
Bukowska, DM; Chen, FK; Viljoen, RD | 1 |
Kim, H; Kim, MK; Lee, CS; Lee, SC; Shin, WB | 1 |
Boon, CJ; Breukink, MB; den Hollander, AI; Hoyng, CB; Keunen, JE; Mohr, JK; Ossewaarde-van Norel, A | 1 |
Chung, YR; Kim, JW; Kim, SW; Lee, K | 1 |
Ansari-Shahrezaei, S; Binder, S; Glittenberg, C; Hagen, S; Krebs, I; Ristl, R; Smretschnig, E | 1 |
Baumann, B; Bühl, W; Gerendas, B; Hitzenberger, CK; Kroisamer, J; Lammer, J; Pircher, M; Roberts, P; Sacu, S; Schmidt-Erfurth, U | 1 |
Hirahara, S; Kominami, A; Nozaki, M; Ogura, Y; Yasukawa, T | 1 |
Feucht, N; Lohmann, CP; Maier, M; Reznicek, L | 1 |
Alagoz, C; Alkin, Z; Garip, R; Ozkaya, A; Perente, I; Taskapili, M; Yazici, AT | 1 |
Alkin, Z; Ozkaya, A; Ozveren, M; Taskapili, M; Yazici, AT | 1 |
Biermasz, NR; Boon, CJ; Dijkman, G; Pereira, AM; van Dijk, EH; van Haalen, FM | 1 |
Chan, SY; Jonas, JB; Wang, Q; Wei, WB | 1 |
Arimura, N; Kawano, H; Kinoshita, T; Kuroiwa, N; Mitamura, Y; Sakamoto, T; Sonoda, S; Uchino, E; Yamashita, T; Yoshihara, N | 1 |
Kuroda, Y; Nakanishi, H; Oishi, A; Ooto, S; Tamura, H; Ueda-Arakawa, N; Yamashiro, K; Yoshimura, N | 1 |
Bakthavatsalam, M; Brelén, ME; Chan, VC; Lai, FH; Luk, FO; Ng, DS; Tsang, CW; Young, AL | 1 |
Fujita, K; Kawamura, A; Mori, R; Shinojima, A; Yasukawa, T; Yuzawa, M | 1 |
Boon, C; Chhablani, J; Mehta, PH; Meyerle, C; Sivaprasad, S | 1 |
Chen, X; Cheng, L; Gong, Y; Mao, L; Weng, S; Yu, S | 1 |
Fujita, K; Kawamura, A; Mori, R; Shinojima, A; Yuzawa, M | 2 |
Akaiwa, K; Egawa, M; Kinoshita, T; Mitamura, Y; Mori, J; Mori, T; Sakamoto, T; Semba, K; Sonoda, S | 1 |
Ambiya, V; Banker, A; Chhablani, J; Li, A; Mehta, P; Meyerele, C; Sarvaiya, C; Shah, S; Singh, R; Wu, L; Yogi, R | 1 |
Byeon, SH; Chung, H; Freund, KB | 1 |
Cheng, Y; Jin, E; Li, S; Li, X; Pan, X; Zhao, M; Zhu, X | 1 |
Chen, GF; Li, SF; Ma, JX; Wang, CL; Yang, AQ; Zhang, TD | 1 |
Avitabile, T; Boscia, F; Cannemi, V; Cardascia, N; Faro, S; Furino, C; Longo, A; Munno, F; Reibaldi, M; Russo, A; Sanfilippo, M; Uva, MG; Zagari, M | 1 |
Komatsu, H; Peyman, GA; Yoneya, S; Young-Devall, J | 1 |
Kwon, OW; Lim, SJ; Roh, MI | 1 |
Nakagawa, S; Ojima, Y; Ooto, S; Tamura, H; Tsujikawa, A; Yamashiro, K; Yoshimura, N | 1 |
Hirose, T; Kawamura, A; Mori, R; Shinojima, A; Yuzawa, M | 1 |
Ojima, Y; Ooto, S; Tamura, H; Tsujikawa, A; Yamashiro, K; Yoshimura, N | 1 |
Yannuzzi, LA | 1 |
Gomi, F; Inoue, R; Sawa, M; Tsujikawa, M | 1 |
Ambresin, A; Bucher, M; Moulin, AP; Nguyen, C; Pournaras, JA | 1 |
Gomi, F; Hamasaki, T; Sasamoto, Y; Sawa, M; Tsujikawa, M | 1 |
Iida, T; Maruko, I; Ogasawara, M; Ojima, A; Spaide, RF; Sugano, Y | 1 |
Kim, MU; Lim, JW; Shin, MC | 1 |
Garg, SJ; Gupta, OP; Hwang, FS; Ip, MS; Jahnle, R; Jain, AK; Kaines, A; Negrey, JN; Pasion, R; Schwartz, SD | 1 |
Chhablani, JK; Narayanan, R | 1 |
Hangai, M; Inoue, T; Mukai, H; Ojima, Y; Ooto, S; Oshima, S; Sakamoto, A; Tsujikawa, A; Yamada, Y; Yamashiro, K; Yoshimura, N | 1 |
Nowroozzadeh, MH | 1 |
Fujita, K; Mori, R; Yuzawa, M | 1 |
Park, KH; Shin, JY; Woo, SJ; Yu, HG | 1 |
Kim, MU; Lim, JW | 1 |
Karacorlu, M; Karacorlu, SA; Ozdemir, H; Senturk, F; Uysal, O | 1 |
Ascaso, FJ; Cohen, SM; Minguez, E; Rojo, M; Yang, SS | 1 |
Balestrazzi, A; Balestrazzi, E; Lumbroso, B; Rispoli, M; Savastano, A; Savastano, MC | 1 |
Chalkiadakis, SE; Karagiannis, DA; Ladas, ID; Makris, NK; Nikas, SD; Peponis, VG | 1 |
Avitabile, T; Boscia, F; Longo, A; Occhipinti, F; Reibaldi, A; Reibaldi, M; Russo, A; Russo, V; Uva, MG; Zagari, M | 1 |
Lim, JW; Shin, MC | 1 |
Iida, T; Maruko, I; Ojima, A; Sekiryu, T; Sugano, Y | 1 |
Freund, KB; Gentile, RC; Jampol, LM; Margolis, R; Miller, JA; Mukkamala, SK; Ober, MD; Sherman, J; Sorenson, JA; Spaide, RF | 1 |
Bae, SH; Chung, H; Heo, JW; Kim, C; Kim, TW; Lee, JY; Moon, SW; Park, TK; Song, SJ | 1 |
Furuta, M; Iida, T; Maruko, I; Sekiryu, T; Sugano, Y | 1 |
Musolino, M; Nicolò, M; Traverso, CE; Zoli, D | 1 |
Barounig, A; El-Shabrawi, Y; Kirschkamp, T; Lindner, E; Weinberger, A | 1 |
Dorecka, M; Gajdzik-Gajdecka, U; Michalska, A; Miniewicz-Kurowska, J; Nita, E; Romaniuk, W | 1 |
Aizman, A; Costa, DL; Gross, NE; Huang, SJ; Klancnik, JM; Slakter, JS; Spaide, RF; Yannuzzi, LA | 1 |
Lee, BR; Shin, YU | 1 |
Hangai, M; Hirata, M; Jirarattanasopa, P; Matsumoto, A; Ooto, S; Tsujikawa, A; Yamashiro, K; Yoshimura, N | 1 |
Lee, BR; Shin, YU; Song, IS | 1 |
Fraser-Bell, S; Gillies, M; Ho, IV; Liew, G; Quin, G | 1 |
Kim, ES; Kim, M; Kim, YG; Kwak, HW; Lee, YS; Yu, SY | 1 |
Gomi, F; Goto, S; Nishida, K; Ueno, C | 1 |
Freund, KB; Fung, AT; Yannuzzi, LA | 1 |
Ansari-Shahrezaei, S; Binder, S; Glittenberg, C; Graf, A; Hagen, S; Krebs, I; Smretschnig, E | 1 |
Kinoshita, S; Koizumi, H; Yamagishi, T; Yamazaki, T | 1 |
Hata, M; Kurimoto, Y; Mandai, M; Nishida, A; Oishi, A; Shimozono, M | 1 |
Barbazetto, I; Larsen, M; Pryds, A; Yannuzzi, L | 1 |
Cho, WB; Chung, H; Kim, HC | 1 |
Gomi, F; Ikuno, Y; Kuroda, S; Nakai, K; Nishida, K; Sawa, M; Tsujikawa, M; Usui, S; Yasuno, Y | 1 |
Cachulo, ML; Cunha-Vaz, JG; Gomez-Ulla, F; Gregório, T; Montero, JA; Murta, JN; Pires, IA; Ruiz-Moreno, JM; Silva, RM | 1 |
Horgan, N; Hungerford, J; Rahman, W | 1 |
Kim, M; Lee, SC; Lee, SJ | 1 |
Bian, AL; Chen, YX; Dong, FT; Li, DH; Li, L; Yang, ZK | 1 |
Ansari-Shahrezaei, S; Binder, S; Glittenberg, C; Hagen, S; Krebs, I; Smretschnig, E | 1 |
Cachulo, ML; de Abreu, JF; Figueira, J; Marques, I; Melo, P; Pires, I; Santos, AR; Silva, R; Vasconcelos, H | 1 |
5 review(s) available for indocyanine green and Central Serous Chorioretinopathy
Article | Year |
---|---|
CENTRAL SEROUS CHORIORETINOPATHY MIMICKING IDIOPATHIC UVEAL EFFUSION SYNDROME.
Topics: Central Serous Chorioretinopathy; Choroid; Choroidal Effusions; Humans; Indocyanine Green; Uveal Effusion Syndrome | 2023 |
Multimodal imaging of pigment epithelial detachment: a guide to evaluation.
Topics: Central Serous Chorioretinopathy; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Multimodal Imaging; Retinal Detachment; Retinal Pigment Epithelium; Tomography, Optical Coherence | 2013 |
System review and meta-analysis on photodynamic therapy in central serous chorioretinopathy.
Topics: Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Laser Coagulation; Photochemotherapy; Photosensitizing Agents; Porphyrins; Ultraviolet Rays; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity | 2014 |
FOCAL CHOROIDAL EXCAVATION AND ITS ASSOCIATION WITH PACHYCHOROID SPECTRUM DISORDERS: A Review of the Literature and Multimodal Imaging Findings.
Topics: Central Serous Chorioretinopathy; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Multimodal Imaging; Retinal Pigment Epithelium; Tomography, Optical Coherence | 2017 |
Diagnosis and interventions for central serous chorioretinopathy: review and update.
Topics: Central Serous Chorioretinopathy; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Laser Coagulation; Tomography, Optical Coherence | 2013 |
10 trial(s) available for indocyanine green and Central Serous Chorioretinopathy
Article | Year |
---|---|
RESPONSE OF CHOROIDAL ABNORMALITIES TO PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: Place Trial Report No. 4.
Topics: Adult; Central Serous Chorioretinopathy; Choroid; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Laser Therapy; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Retina; Subretinal Fluid; Tomography, Optical Coherence; Verteporfin; Visual Acuity | 2021 |
Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy.
Topics: Adult; Central Serous Chorioretinopathy; Choroid; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Laser Therapy; Male; Middle Aged; Observer Variation; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Ultraviolet Rays; Verteporfin; Visual Acuity | 2020 |
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial.
Topics: Adult; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Cross-Over Studies; Double-Blind Method; Female; Fluorescein Angiography; Humans; Indocyanine Green; Lasers, Semiconductor; Light Coagulation; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Quality of Life; Sickness Impact Profile; Subretinal Fluid; Surveys and Questionnaires; Tomography, Optical Coherence; Treatment Failure; Visual Acuity | 2020 |
Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Double-Blind Method; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Low-Level Light Therapy; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Ranibizumab; Retina; Subretinal Fluid; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2014 |
A 50% vs 30% dose of verteporfin (photodynamic therapy) for acute central serous chorioretinopathy: one-year results of a randomized clinical trial.
Topics: Acute Disease; Adult; Capillary Permeability; Central Serous Chorioretinopathy; Coloring Agents; Double-Blind Method; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Subretinal Fluid; Tomography, Optical Coherence; Verteporfin | 2015 |
OCT Angiography Compared to Fluorescein and Indocyanine Green Angiography in Chronic Central Serous Chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Chronic Disease; Coloring Agents; Contrast Media; Female; Fluorescein; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Indocyanine Green; Male; Middle Aged; Reproducibility of Results; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2015 |
Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial.
Topics: Adult; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Serum; Treatment Outcome; Verteporfin; Visual Acuity | 2010 |
Functional retinal changes measured by microperimetry in standard-fluence vs low-fluence photodynamic therapy in chronic central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Chronic Disease; Female; Fixation, Ocular; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Retina; Sensitivity and Specificity; Tomography, Optical Coherence; Verteporfin; Visual Acuity; Visual Field Tests; Visual Fields | 2011 |
A randomized pilot study of low-fluence photodynamic therapy versus intravitreal ranibizumab for chronic central serous chorioretinopathy.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Ranibizumab; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2011 |
Intravitreal ranibizumab for acute central serous chorioretinopathy.
Topics: Acute Disease; Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Prospective Studies; Ranibizumab; Retinal Detachment; Treatment Outcome; Visual Acuity | 2013 |
177 other study(ies) available for indocyanine green and Central Serous Chorioretinopathy
Article | Year |
---|---|
MYOPIC PRESENTATION OF CENTRAL SEROUS CHORIORETINOPATHY.
Topics: Adult; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Cross-Sectional Studies; Emmetropia; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Myopia; Visual Acuity | 2021 |
Navigated micropulse laser for central serous chorioretinopathy: Efficacy, safety, and predictive factors of treatment response.
Topics: Central Serous Chorioretinopathy; Chronic Disease; Female; Fluorescein Angiography; Humans; Indocyanine Green; Lasers; Male; Middle Aged; Photochemotherapy; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2022 |
Choroidal vascular alterations evaluated by ultra-widefield indocyanine green angiography in central serous chorioretinopathy.
Topics: Case-Control Studies; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Fluorescein Angiography; Humans; Hyperemia; Indocyanine Green; Retrospective Studies; Tomography, Optical Coherence | 2022 |
Comparison of Indocyanine Green Angiography and Fluorescein Angiography for Imaging of Central Serous Chorioretinopathy Patients as Candidates for Photodynamic Therapy.
Topics: Adult; Central Serous Chorioretinopathy; Coloring Agents; Cross-Sectional Studies; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2022 |
SAUSAGING AND BULBOSITIES OF THE CHOROIDAL VEINS IN CENTRAL SEROUS CHORIORETINOPATHY.
Topics: Central Serous Chorioretinopathy; Choroid; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Retrospective Studies; Tomography, Optical Coherence | 2022 |
Distinct characteristics of central serous chorioretinopathy according to gender.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence | 2022 |
LOCATIONAL AGREEMENT OF NEAR-INFRARED AUTOFLUORESCENCE WITH CHOROIDAL VASCULAR HYPERPERMEABILITY IN CENTRAL SEROUS CHORIORETINOPATHY.
Topics: Central Serous Chorioretinopathy; Choroid; Fluorescein Angiography; Humans; Indocyanine Green; Retrospective Studies; Tomography, Optical Coherence | 2022 |
Comparison of swept-source OCTA and indocyanine green angiography in central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Choroid; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Tomography, Optical Coherence | 2022 |
The Temporal Topography of Central Serous Chorioretinopathy in the Chinchilla Rabbits Induced by Intravenous Injection of Adrenaline: An in vivo Study.
Topics: Animals; Central Serous Chorioretinopathy; Choroid; Eosine Yellowish-(YS); Epinephrine; Fluorescein Angiography; Hematoxylin; Humans; Indocyanine Green; Injections, Intravenous; Rabbits; Tomography, Optical Coherence | 2022 |
En face Ultrawidefield OCT of the Vortex Vein System in Central Serous Chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Retrospective Studies; Tomography, Optical Coherence | 2023 |
Individual vs. combined imaging modalities for diagnosing neovascular central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Choroidal Neovascularization; Fluorescein Angiography; Humans; Indocyanine Green; Retina; Retrospective Studies; Tomography, Optical Coherence | 2023 |
Comparison of the fluorescein angiography-guided and indocyanine green angiography-guided photodynamic therapy in the treatment of non-resolving central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Chronic Disease; Fluorescein Angiography; Humans; Indocyanine Green; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Retrospective Studies; Tomography, Optical Coherence; Verteporfin | 2023 |
Relationship between macular intervortex vein anastomosis and optical coherence tomography biomarkers in chronic central serous chorioretinopathy.
Topics: Adult; Anastomosis, Surgical; Central Serous Chorioretinopathy; Choroid; Chronic Disease; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Tomography, Optical Coherence | 2023 |
INDOCYANINE GREEN ANGIOGRAPHY OF TYPE 1 MACULAR NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION AND CENTRAL SEROUS CHORIORETINOPATHY REVEALS DIFFERENT DISEASE MECHANISMS.
Topics: Central Serous Chorioretinopathy; Choroidal Neovascularization; Endothelial Growth Factors; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Retrospective Studies; Tomography, Optical Coherence | 2023 |
Radiation chorioretinopathy: unusual occurrence of intervortex venous anastomosis.
Topics: Anastomosis, Surgical; Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Female; Fluorescein Angiography; Humans; Indocyanine Green; Retinal Diseases; Tomography, Optical Coherence | 2023 |
Combined central serous chorioretinopathy, hypermetropia, short axial length, chorioretinal folds, enlarged/thickened ocular coats, with varying association of scleral changes (CHAFES).
Topics: Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Female; Fluorescein Angiography; Humans; Hyperopia; Indocyanine Green; Male; Retrospective Studies; Sclera; Tomography, Optical Coherence | 2023 |
Choroidal Vein Alterations in Pachychoroid Disease With Choroidal Vascular Hyperpermeability: Evaluated by Wide-Field Indocyanine Green Angiography.
Topics: Adult; Angiography; Central Serous Chorioretinopathy; Choroid; Female; Humans; Indocyanine Green; Male; Middle Aged; Retrospective Studies | 2023 |
Pupillary Light Reflex and Multimodal Imaging in Patients With Central Serous Chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Choroid; Chronic Disease; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Multimodal Imaging; Retrospective Studies; Tomography, Optical Coherence | 2023 |
Identifying central serous chorioretinopathy biomarkers in coexisting diabetic retinopathy: a multimodal imaging study.
Topics: Acute Disease; Adult; Aged; Biomarkers; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Cross-Sectional Studies; Diabetic Retinopathy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2020 |
FLAT IRREGULAR PIGMENT EPITHELIUM DETACHMENT IN CENTRAL SEROUS CHORIORETINOPATHY: A Form of Pachychoroid Neovasculopathy?
Topics: Adult; Angiogenesis Inhibitors; Bevacizumab; Central Serous Chorioretinopathy; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Retinal Detachment; Retinal Pigment Epithelium; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2020 |
SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome.
Topics: Adolescent; Adult; Aged; Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Choroid; Choroidal Neovascularization; Coloring Agents; Diagnosis, Differential; Diagnostic Errors; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Multimodal Imaging; Optical Imaging; Retinal Detachment; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Vitelliform Macular Dystrophy; Wet Macular Degeneration; Young Adult | 2020 |
Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy.
Topics: Aged; Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Choroidal Neovascularization; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Multimodal Imaging; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2020 |
CLINICAL CHARACTERISTICS AND OUTCOME OF POSTERIOR CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Edema; Male; Middle Aged; Multimodal Imaging; Photochemotherapy; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Visual Acuity | 2020 |
Comparison of Focal and Conventional Verteporfin Photodynamic Therapy for Chronic Central Serous Chorioretinopathy.
Topics: Adult; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2019 |
Effect of Acetazolamide on Choroidal Morphology in Central Serous Chorioretinopathy.
Topics: Acetazolamide; Adult; Carbonic Anhydrase Inhibitors; Case-Control Studies; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Visual Acuity | 2019 |
OCTA characterisation of microvascular retinal alterations in patients with central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Microaneurysm; Microvessels; Middle Aged; Multimodal Imaging; Retinal Telangiectasis; Retinal Vessels; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2020 |
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FEATURES OF FOCAL CHOROIDAL EXCAVATION AND THE CHOROIDAL STROMA VARIATIONS WITH OCCURRENCE OF EXCAVATION.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Retinal Vessels; Stromal Cells; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2020 |
CHANGES IN CHORIOCAPILLARIS, SATTLER, AND HALLER LAYER THICKNESSES IN CENTRAL SEROUS CHORIORETINOPATHY AFTER HALF-FLUENCE PHOTODYNAMIC THERAPY.
Topics: Adult; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Organ Size; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Tomography, Optical Coherence; Verteporfin; Visual Acuity | 2020 |
Three-year follow-up of choroidal neovascularisation in eyes of chronic central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroidal Neovascularization; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Retrospective Studies; Subretinal Fluid; Time Factors; Tomography, Optical Coherence; Visual Acuity | 2020 |
Response of neovascular central serous chorioretinopathy to an extended upload of anti-VEGF agents.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Multimodal Imaging; Ranibizumab; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2020 |
Choriocapillaris Integrity in Relapsed Central Serous Chorioretinopathy in a Patient Treated With Fingolimod for Multiple Sclerosis: New Insights From Optical Coherence Tomography Angiography.
Topics: Adult; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Fingolimod Hydrochloride; Fluorescein Angiography; Humans; Immunosuppressive Agents; Indocyanine Green; Male; Multiple Sclerosis, Relapsing-Remitting; Recurrence; Tomography, Optical Coherence; Visual Acuity | 2021 |
Optical coherence tomography angiography of flat irregular pigment epithelial detachments in central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Organ Size; Retinal Detachment; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2021 |
Minoxidil induced central serous Chorioretinopathy treated with oral Eplerenone - a case report.
Topics: Administration, Oral; Adult; Alopecia; Central Serous Chorioretinopathy; Coloring Agents; Eplerenone; Fluorescein Angiography; Humans; Indocyanine Green; Male; Mineralocorticoid Receptor Antagonists; Minoxidil; Tomography, Optical Coherence; Vasodilator Agents; Visual Acuity | 2020 |
Quantitative Assessment of Asymmetric Choroidal Outflow in Pachychoroid Eyes on Ultra-Widefield Indocyanine Green Angiography.
Topics: Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Reproducibility of Results; Veins; Visual Acuity | 2020 |
Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Topics: Adult; Aged; Alleles; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Complement Factor H; Female; Fluorescein Angiography; Gene Expression; Gene Frequency; Gene-Environment Interaction; Heterozygote; Homozygote; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Proteins; Retrospective Studies; Subretinal Fluid; Treatment Outcome; Verteporfin; Visual Acuity | 2020 |
Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Chronic Disease; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Verteporfin; Visual Acuity | 2020 |
Quantitative Evaluation of Retinal Vessel Density in Central Serous Chorioretinopathy after Half-dose Photodynamic Therapy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Lasers; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Retinal Vessels; Tomography, Optical Coherence; Verteporfin; Visual Acuity | 2021 |
OCT Risk Factors for 3-Year Development of Macular Complications in Eyes With "Resolved" Chronic Central Serous Chorioretinopathy.
Topics: Adult; Atrophy; Central Serous Chorioretinopathy; Choroidal Neovascularization; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Macular Edema; Male; Middle Aged; Retinal Pigment Epithelium; Retrospective Studies; Risk Factors; Subretinal Fluid; Tomography, Optical Coherence; Visual Acuity | 2021 |
Early alterations in retinal microvasculature on swept-source optical coherence tomography angiography in acute central serous chorioretinopathy.
Topics: Adult; Central Serous Chorioretinopathy; Choroid; Cohort Studies; Coloring Agents; Female; Fluorescein Angiography; Hemodynamics; Humans; Indocyanine Green; Male; Microvessels; Middle Aged; Retina; Retinal Vessels; Subretinal Fluid; Tomography, Optical Coherence | 2021 |
Choroidal and Retinal Changes After Systemic Adrenaline and Photodynamic Therapy in Non-Human Primates.
Topics: Animals; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Combined Modality Therapy; Epinephrine; Fluorescein Angiography; Indocyanine Green; Macaca fascicularis; Male; Mydriatics; Photochemotherapy; Photosensitizing Agents; Retina; Tomography, Optical Coherence; Verteporfin | 2021 |
The morphology of choroidal neovascularization in chronic central serous chorioretinopathy presenting with flat, irregular pigment epithelium detachment.
Topics: Central Serous Chorioretinopathy; Choroid; Choroidal Neovascularization; Coloring Agents; Epithelium; Fluorescein Angiography; Humans; Indocyanine Green; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2021 |
Optical Coherence Tomography Angiography Compared with Multimodal Imaging for Diagnosing Neovascular Central Serous Chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Choroid; Choroidal Neovascularization; Cross-Sectional Studies; Fluorescein Angiography; Humans; Indocyanine Green; Multimodal Imaging; Prospective Studies; Retrospective Studies; Tomography, Optical Coherence | 2021 |
Clinical characteristics of central serous chorioretinopathy in patients by age.
Topics: Aged; Central Serous Chorioretinopathy; Choroid; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence | 2021 |
POLYPOIDAL CHOROIDAL VASCULOPATHY ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY: Pachychoroid Spectrum of Diseases.
Topics: Aged; Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Retinal Detachment; Retinal Pigment Epithelium; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence | 2018 |
Multimodal assessment of patients with chronic central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Chronic Disease; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retinal Pigment Epithelium; Time Factors; Tomography, Optical Coherence; Visual Acuity | 2017 |
Topography-guided identification of leakage point in central serous chorioretinopathy: a base for fluorescein angiography-free focal laser photocoagulation.
Topics: Adult; Central Serous Chorioretinopathy; Coloring Agents; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Indocyanine Green; Laser Coagulation; Male; Ophthalmoscopy; Retinal Pigment Epithelium; Retrospective Studies; Surgery, Computer-Assisted; Tomography, Optical Coherence; Visual Acuity | 2018 |
Response of central serous chorioretinopathy evaluated by multimodal retinal imaging.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Eplerenone; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Multimodal Imaging; Prospective Studies; Tomography, Optical Coherence | 2018 |
Early choriocapillaris changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy evaluated by optical coherence tomography angiography: Preliminary results.
Topics: Adult; Central Serous Chorioretinopathy; Choroid; Female; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2018 |
Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group.
Topics: Adult; Central Serous Chorioretinopathy; Chronic Disease; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Laser Therapy; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2018 |
Angiographic and Tomographic Prognostic Factors of Chronic Central Serous Chorioretinopathy Treated with Half-Dose Photodynamic Therapy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prognosis; Retina; Tomography, Optical Coherence; Verteporfin; Visual Acuity | 2018 |
Findings of OCT-angiography compared to fluorescein and indocyanine green angiography in central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence | 2018 |
Clinical Features of Central Serous Chorioretinopathy With Type 1 Choroidal Neovascularization.
Topics: Acute Disease; Adult; Aged; Central Serous Chorioretinopathy; Choroidal Neovascularization; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retrospective Studies; Risk Factors; Tomography, Optical Coherence; Visual Acuity | 2018 |
Smokestack leak on indocyanine green angiography in acute central serous chorioretinopathy.
Topics: Acute Disease; Central Serous Chorioretinopathy; Coloring Agents; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green | 2018 |
Commentary: Smoke stack leak on indocyanine green angiography in acute central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Choroid; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Smoke; Tomography, Optical Coherence | 2018 |
Association of Central Serous Chorioretinopathy with Psychosocial Factors is Dependent on Its Phase and Subtype.
Topics: Adult; Anxiety Disorders; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Depressive Disorder; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Prospective Studies; Stress, Psychological | 2018 |
Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2018 |
ASSOCIATION BETWEEN CHOROIDAL CAVERNS AND CHOROIDAL VASCULAR HYPERPERMEABILITY IN EYES WITH PACHYCHOROID DISEASES.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence | 2018 |
GENETIC RISK FACTORS IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY.
Topics: Acute Disease; Adult; Aged; Case-Control Studies; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Complement C4b; Complement Factor H; Female; Fluorescein Angiography; Gene Dosage; Genetic Predisposition to Disease; Genotyping Techniques; Humans; Indocyanine Green; Male; Middle Aged; Ophthalmoscopy; Phenotype; Polymorphism, Single Nucleotide; Proteins; Receptors, Mineralocorticoid; Risk Factors; Tomography, Optical Coherence | 2019 |
Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy.
Topics: Adult; Aged; Angiography; Capillaries; Central Serous Chorioretinopathy; Coloring Agents; Eye; Female; Hemodynamics; Humans; Indocyanine Green; Male; Middle Aged; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Veins | 2018 |
Abnormal choroidal flow on optical coherence tomography angiography in central serous chorioretinopathy.
Topics: Adult; Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Choroid; Ciliary Arteries; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Regional Blood Flow; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2019 |
Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy.
Topics: Adult; Aged; Aged, 80 and over; Central Serous Chorioretinopathy; Choroidal Neovascularization; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Longitudinal Studies; Macular Edema; Male; Middle Aged; Multimodal Imaging; Optical Imaging; Photography; Retinal Degeneration; Retrospective Studies; Vision Disorders; Visual Acuity | 2019 |
Optical Coherence Tomography Angiography Compared with Indocyanine Green Angiography in Central Serous Chorioretinopathy.
Topics: Adult; Angiography; Central Serous Chorioretinopathy; Choroid; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Tomography, Optical Coherence | 2019 |
Choroidal Neovascularisation Complicating Chronic Central Serous Chorioretinopathy: The Discovery Rate on Multimodal Imaging.
Topics: Central Serous Chorioretinopathy; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Multimodal Imaging; Tomography, Optical Coherence; Visual Acuity | 2019 |
Predictive Genes for the Prognosis of Central Serous Chorioretinopathy.
Topics: Adult; Central Serous Chorioretinopathy; Choroidal Neovascularization; Coloring Agents; Complement Factor H; Female; Fluorescein Angiography; Genotype; Humans; Indocyanine Green; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Proteins; Receptors, Vasoactive Intestinal Peptide, Type II; Retinal Detachment; Retrospective Studies | 2019 |
Concentric retinal pigment epithelium tear in central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Male; Retinal Detachment; Retinal Perforations; Retinal Pigment Epithelium; Tomography, Optical Coherence; Young Adult | 2019 |
Flat irregular pigment epithelium detachment in central serous chorioretinopathy: Correlation with choroidal neovascular membrane.
Topics: Central Serous Chorioretinopathy; Choroid; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retinal Detachment; Retinal Pigment Epithelium; Tomography, Optical Coherence; Vision Disorders; Visual Acuity | 2019 |
Efficacy of half-fluence photodynamic therapy depending on the degree of choroidal hyperpermeability in chronic central serous chorioretinopathy.
Topics: Adult; Aged; Capillary Permeability; Central Serous Chorioretinopathy; Choroid; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intraoperative Complications; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Postoperative Complications; Prospective Studies; Recurrence; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2013 |
Optical coherence tomographic enhanced depth imaging of polypoidal choroidal vasculopathy.
Topics: Bruch Membrane; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Prospective Studies; Retinal Pigment Epithelium; Tomography, Optical Coherence; Visual Acuity | 2013 |
Focal choroidal excavation in eyes with central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Imaging, Three-Dimensional; Indocyanine Green; Male; Middle Aged; Prevalence; Prospective Studies; Tomography, Optical Coherence; Visual Acuity | 2013 |
Unusual presentations of type 2 idiopathic macular telangiectasia.
Topics: Aged; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retinal Drusen; Retinal Telangiectasis; Retinal Vessels; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2013 |
Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Hypertrophy; Indocyanine Green; Male; Middle Aged; Retina; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2014 |
Increased fundus autofluorescence related to outer retinal disruption.
Topics: Adult; Central Serous Chorioretinopathy; Choroiditis; Coloring Agents; Female; Fluorescein Angiography; Fluorescence; Fundus Oculi; Humans; Indocyanine Green; Male; Middle Aged; Retinal Diseases; Retinal Photoreceptor Cell Outer Segment; Retinal Pigments; Tomography, Optical Coherence | 2013 |
En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Choroid; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Prospective Studies; Retinal Pigment Epithelium; Tomography, Optical Coherence; Visual Acuity | 2014 |
Assessment of choroidal topographic changes by swept source optical coherence tomography after photodynamic therapy for central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Imaging, Three-Dimensional; Indocyanine Green; Male; Middle Aged; Organ Size; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Tomography, Optical Coherence; Topography, Medical; Verteporfin | 2014 |
Clinical and spectral-domain optical coherence tomography findings in patients with focal choroidal excavation.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Eye Abnormalities; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intraocular Pressure; Male; Middle Aged; Organ Size; Polyps; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2014 |
Early visual and morphologic changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
Topics: Adult; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Fovea Centralis; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Visual Acuity | 2014 |
The extended clinical phenotype of dome-shaped macula.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Central Serous Chorioretinopathy; Child; Choroid; Choroidal Neovascularization; Cohort Studies; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macula Lutea; Male; Middle Aged; Multimodal Imaging; Myopia; Phenotype; Retinal Diseases; Retrospective Studies; Sclera; Tomography, Optical Coherence; Ultrasonography; Visual Acuity; Young Adult | 2014 |
Half-fluence versus half-dose photodynamic therapy in chronic central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2014 |
Diagnostic and therapeutic challenges.
Topics: Central Serous Chorioretinopathy; Coloring Agents; Diagnosis, Differential; Female; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Retinal Detachment; Retinal Pigment Epithelium; Tomography, Optical Coherence; Vision Disorders; Visual Acuity | 2015 |
Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Coloring Agents; Diagnosis, Differential; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Indocyanine Green; Male; Middle Aged; Optical Imaging; Reproducibility of Results; Retinal Pigment Epithelium; Retrospective Studies; Severity of Illness Index; Tomography, Optical Coherence; Visual Acuity | 2014 |
Morphologic features of focal choroidal excavation on spectral domain optical coherence tomography with simultaneous angiography.
Topics: Adult; Aged; Aged, 80 and over; Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Polyps; Tomography, Optical Coherence | 2014 |
Central serous chorioretinopathy in patients receiving exogenous testosterone therapy.
Topics: Adult; Androgens; Central Serous Chorioretinopathy; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retrospective Studies; Risk Factors; Testosterone; Tomography, Optical Coherence; Vision Disorders; Visual Acuity | 2014 |
Evaluation of focal choroidal excavation in the macula using swept-source optical coherence tomography.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid Diseases; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Geographic Atrophy; Humans; Indocyanine Green; Macula Lutea; Male; Middle Aged; Polyps; Prospective Studies; Tomography, Optical Coherence; Young Adult | 2014 |
Retinal sensitivity assessed by microperimetry and corresponding retinal structure and thickness in resolved central serous chorioretinopathy.
Topics: Adult; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retina; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Visual Field Tests; Visual Fields | 2014 |
Effect of photodynamic therapy on short-wavelength fundus autofluorescence in eyes with acute central serous chorioretinopathy.
Topics: Acute Disease; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Male; Middle Aged; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Pigment Epithelium; Retrospective Studies; Verteporfin | 2015 |
Punctate hyperfluorescence spot as a common choroidopathy of central serous chorioretinopathy and polypoidal choroidal vasculopathy.
Topics: Aged; Central Serous Chorioretinopathy; Choroid; Choroidal Neovascularization; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Polyps; Retrospective Studies; Tomography, Optical Coherence; Wet Macular Degeneration | 2014 |
[Photodynamic therapy in a patient with chronic central serous chorioretinopathy--a case report].
Topics: Central Serous Chorioretinopathy; Coloring Agents; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2014 |
Nondamaging photothermal therapy for the retina: initial clinical experience with chronic central serous retinopathy.
Topics: Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Laser Coagulation; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Visual Acuity | 2015 |
Pachychoroid neovasculopathy.
Topics: Capillary Permeability; Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Multimodal Imaging; Retinal Pigment Epithelium; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence | 2015 |
Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Central Serous Chorioretinopathy; Choroid; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Organ Size; Prospective Studies; Tomography, Optical Coherence; Visual Acuity | 2014 |
Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration.
Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Complement Factor H; Female; Fluorescein Angiography; Gene Frequency; Genetic Association Studies; Genotyping Techniques; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Multimodal Imaging; Ophthalmoscopy; Polymorphism, Single Nucleotide; Proteins; Tomography, Optical Coherence; Young Adult | 2015 |
One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.
Topics: Adult; Aged; Aged, 80 and over; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Detachment; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2015 |
Intravitreal aflibercept for choroidal neovascularisation complicating chronic central serous chorioretinopathy.
Topics: Aged; Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Choroidal Neovascularization; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Subretinal Fluid; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Choroidal thickness and choroidal blood flow after intravitreal bevacizumab injection in eyes with central serous chorioretinopathy.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Blood Flow Velocity; Blood Pressure; Central Serous Chorioretinopathy; Choroid; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Heart Rate; Humans; Indocyanine Green; Intraocular Pressure; Intravitreal Injections; Laser-Doppler Flowmetry; Male; Middle Aged; Organ Size; Prospective Studies; Regional Blood Flow; Retina; Vascular Endothelial Growth Factor A; Visual Acuity | 2015 |
Change of regional choroid thickness after reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Imaging, Three-Dimensional; Indocyanine Green; Male; Middle Aged; Organ Size; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Tomography, Optical Coherence; Visual Acuity | 2015 |
Multimodal Imaging and Choroidal Volumetric Changes After Half-fluence PDT in Central Serous Chorioretinopathy.
Topics: Adult; Capillary Permeability; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Verteporfin; Visual Acuity | 2016 |
Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome.
Topics: Adult; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Laser Coagulation; Lasers, Semiconductor; Male; Middle Aged; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Visual Acuity; Visual Field Tests; Visual Fields | 2015 |
Central serous chorioretinopathy fundus autofluorescence comparison with two different confocal scanning laser ophthalmoscopes.
Topics: Adult; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Laser Coagulation; Macular Degeneration; Male; Middle Aged; Ophthalmoscopes; Ophthalmoscopy; Optical Imaging; Photochemotherapy; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence | 2015 |
Flat irregular retinal pigment epithelium detachments in chronic central serous chorioretinopathy and choroidal neovascularization.
Topics: Adolescent; Adult; Aged; Central Serous Chorioretinopathy; Choroid; Choroidal Neovascularization; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Retinal Detachment; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2015 |
Conversion of central serous chorioretinopathy to polypoidal choroidal vasculopathy.
Topics: Central Serous Chorioretinopathy; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Laser Coagulation; Middle Aged; Polyps; Retinal Detachment; Tomography, Optical Coherence | 2015 |
Focal choroidal excavation in patients with central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retinal Detachment; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2015 |
Central serous chorioretinopathy treated with navigated retinal laser photocoagulation: visual acuity and retinal sensitivity.
Topics: Acute Disease; Adult; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Laser Coagulation; Male; Middle Aged; Prospective Studies; Retina; Subretinal Fluid; Tomography, Optical Coherence; Visual Acuity; Visual Field Tests; Visual Fields | 2015 |
Choroidal Thickness Changes After Photodynamic Therapy and Recurrence of Chronic Central Serous Chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Organ Size; Photochemotherapy; Photosensitizing Agents; Porphyrins; Recurrence; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence; Verteporfin; Visual Acuity | 2015 |
CHOROIDAL NEOVASCULARIZATION IN CAUCASIAN PATIENTS WITH LONGSTANDING CENTRAL SEROUS CHORIORETINOPATHY.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroidal Neovascularization; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Polyps; Retrospective Studies; Tomography, Optical Coherence; White People | 2015 |
Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography.
Topics: Central Serous Chorioretinopathy; Choroid; Chronic Disease; Coloring Agents; Female; Fluorescein; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retinal Detachment; Retinal Pigment Epithelium; Subretinal Fluid; Tomography, Optical Coherence; Visual Acuity | 2015 |
The hyper-fluorescent transitional bands in ultra-late phase of indocyanine green angiography in chronic central serous chorioretinopathy.
Topics: Adult; Central Serous Chorioretinopathy; Female; Fluorescent Dyes; Humans; Indocyanine Green; Male; Middle Aged; Optical Imaging; Retrospective Studies; Tomography, Optical Coherence | 2016 |
Classification of image artefacts in optical coherence tomography angiography of the choroid in macular diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Artifacts; Central Serous Chorioretinopathy; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Observer Variation; Polyps; Retrospective Studies; Tomography, Optical Coherence | 2016 |
Comparison of the Clinical Manifestations between Acute Vogt-Koyanagi-Harada Disease and Acute Bilateral Central Serous Chorioretinopathy.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Central Serous Chorioretinopathy; Female; Fluorescein Angiography; Humans; Hyperemia; Indocyanine Green; Male; Middle Aged; Multimodal Imaging; Ophthalmoscopy; Optic Disk; Photography; Retinal Detachment; Retinal Pigment Epithelium; Retrospective Studies; Slit Lamp Microscopy; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Young Adult | 2015 |
Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Laser Therapy; Lasers, Semiconductor; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Tomography, Optical Coherence; Verteporfin; Visual Acuity | 2016 |
CHOROIDAL THICKNESS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: Assessment of Haller and Sattler Layers.
Topics: Aged; Capillaries; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Muscle, Smooth, Vascular; Observer Variation; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2016 |
Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy.
Topics: Adult; Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Choroidal Neovascularization; Chronic Disease; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Vascular Endothelial Growth Factor A; Verteporfin | 2016 |
Retinal Pigment Epithelial Features in Central Serous Chorioretinopathy Identified by Polarization-Sensitive Optical Coherence Tomography.
Topics: Adult; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Prospective Studies; Retinal Detachment; Retinal Pigment Epithelium; Tomography, Optical Coherence | 2016 |
Densitometry of Choroidal Vessels in Eyes With and Without Central Serous Chorioretinopathy by Wide-Field Indocyanine Green Angiography.
Topics: Aged; Angiography, Digital Subtraction; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Densitometry; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Reproducibility of Results; Retinal Vessels; Retrospective Studies; Visual Acuity | 2016 |
OCT Angiography Findings in Acute Central Serous Chorioretinopathy.
Topics: Acute Disease; Adult; Blood-Retinal Barrier; Capillary Permeability; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Optical Imaging; Regional Blood Flow; Retinal Detachment; Subretinal Fluid; Tomography, Optical Coherence | 2016 |
The role of indocyanine green angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Choroidal Neovascularization; Coloring Agents; Cross-Sectional Studies; Diagnosis, Differential; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Ranibizumab; Retinal Detachment; Retrospective Studies; Vascular Endothelial Growth Factor A; Vitelliform Macular Dystrophy; Wet Macular Degeneration | 2016 |
The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study.
Topics: Acute Disease; Adult; Case-Control Studies; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Recurrence; Remission, Spontaneous; Retrospective Studies; Time Factors; Verteporfin; Visual Acuity | 2016 |
Chronic central serous chorioretinopathy as a presenting symptom of Cushing syndrome.
Topics: Adult; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Cushing Syndrome; Female; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Retrospective Studies; Subretinal Fluid; Visual Acuity | 2016 |
OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY.
Topics: Adult; Aged; Capillaries; Capillary Permeability; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Visual Acuity | 2016 |
Structural Changes of Inner and Outer Choroid in Central Serous Chorioretinopathy Determined by Optical Coherence Tomography.
Topics: Adult; Angiography; Central Serous Chorioretinopathy; Choroid; Edema; Female; Fluorescein; Humans; Indocyanine Green; Inflammation; Male; Middle Aged; Refractive Errors; Refractometry; Retrospective Studies; Tomography, Optical Coherence | 2016 |
Increased Choroidal Vascularity in Central Serous Chorioretinopathy Quantified Using Swept-Source Optical Coherence Tomography.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Imaging, Three-Dimensional; Indocyanine Green; Male; Microvessels; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Visual Acuity | 2016 |
A Multicenter Study on the Long-term Outcomes of Half-dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
Topics: Adult; Aged; Aged, 80 and over; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prognosis; Recurrence; Retrospective Studies; Tomography, Optical Coherence; Verteporfin; Visual Acuity | 2016 |
Investigation of the Etiology of Central Serous Chorioretinopathy Using En-Face Optical Coherence Tomography and Indocyanine Green Angiography.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Indocyanine Green; Male; Middle Aged; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2016 |
Preferred practice pattern in central serous chorioretinopathy.
Topics: Angiogenesis Inhibitors; Central Serous Chorioretinopathy; Fluorescein Angiography; Humans; Indocyanine Green; Laser Coagulation; Optical Imaging; Photochemotherapy; Photosensitizing Agents; Porphyrins; Practice Patterns, Physicians'; Prospective Studies; Tomography, Optical Coherence | 2017 |
Detection of Choroidal Neovascularization in Central Serous Chorioretinopathy Using Optical Coherence Tomographic Angiography.
Topics: Central Serous Chorioretinopathy; Choroid; Choroidal Neovascularization; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Indocyanine Green; Male; Retina; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2016 |
Findings of Optical Coherence Tomographic Angiography at the Choriocapillaris Level in Central Serous Chorioretinopathy.
Topics: Adult; Capillaries; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Male; Middle Aged; Retinal Vessels; Tomography, Optical Coherence; Visual Acuity | 2016 |
Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy.
Topics: Adult; Aged; Aged, 80 and over; Central Serous Chorioretinopathy; Choroid; Chronic Disease; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Tomography, Optical Coherence | 2016 |
Subfoveal choroidal thickness as a predictor of central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Choroid; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Predictive Value of Tests; Regression Analysis; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2016 |
Sensitivity and specificity of multispectral imaging in detecting central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Optical Imaging; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, Optical Coherence | 2017 |
[The analysis of fundus fluorescein angiography, indocyanine green angiography and hemodynamics of retrobulbar blood vessels in central serous chorioretinopathy].
Topics: Adult; Case-Control Studies; Central Serous Chorioretinopathy; Eye; Female; Fluorescein Angiography; Fundus Oculi; Hemodynamics; Humans; Indocyanine Green; Male; Middle Aged; Ophthalmic Artery; Radiography | 2009 |
Choriocapillary blood propagation in normal volunteers and in patients with central serous chorioretinopathy.
Topics: Adult; Aged; Aged, 80 and over; Arterioles; Capillaries; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Prospective Studies; Regional Blood Flow; Video Recording; Young Adult | 2010 |
Intravitreal bevacizumab injection for central serous chorioretinopathy.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Injections; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography.
Topics: Adult; Capillary Permeability; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retinal Detachment; Retrospective Studies; Tomography, Optical Coherence | 2010 |
Morphologic findings in acute central serous chorioretinopathy using spectral domain-optical coherence tomography with simultaneous angiography.
Topics: Acute Disease; Adult; Capillary Permeability; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retinal Pigment Epithelium; Retinal Vessels; Tomography, Optical Coherence | 2010 |
Restoration of outer segments of foveal photoreceptors after resolution of central serous chorioretinopathy.
Topics: Acute Disease; Adult; Aged; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Fovea Centralis; Humans; Indocyanine Green; Laser Coagulation; Male; Middle Aged; Photochemotherapy; Recurrence; Retinal Detachment; Retinal Photoreceptor Cell Outer Segment; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2010 |
Central serous chorioretinopathy: a personal perspective.
Topics: Capillary Permeability; Central Serous Chorioretinopathy; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Photochemotherapy; Prognosis | 2010 |
Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Recurrence; Treatment Outcome; Verteporfin; Visual Acuity | 2010 |
Fluorescein and indocyanine green angiography findings in B cell lymphoblastic leukemia mimicking acute central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Choroid Neoplasms; Female; Fluorescein Angiography; Humans; Indocyanine Green; Middle Aged; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Retinal Neoplasms; Retinoscopy | 2010 |
Macular pigment optical density in central serous chorioretinopathy.
Topics: Acute Disease; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Lutein; Male; Middle Aged; Retina; Retinal Pigments; Spectrometry, Fluorescence; Tomography, Optical Coherence; Visual Acuity; Xanthophylls; Zeaxanthins | 2010 |
Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
Topics: Adult; Aged; Capillary Permeability; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Exudates and Transudates; Female; Fluorescein Angiography; Fovea Centralis; Humans; Indocyanine Green; Laser Coagulation; Male; Middle Aged; Organ Size; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Verteporfin; Visual Acuity | 2010 |
Aqueous humor and plasma levels of vascular endothelial growth factor and interleukin-8 in patients with central serous chorioretinopathy.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aqueous Humor; Bevacizumab; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Interleukin-8; Intravitreal Injections; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2010 |
Diagnostic and therapeutic challenges.
Topics: Adenoma; Adrenal Cortex Neoplasms; Adult; Body Fluids; Central Serous Chorioretinopathy; Exudates and Transudates; Fluorescein Angiography; Humans; Hydrocortisone; Indocyanine Green; Male; Tomography, Optical Coherence; Vision Disorders; Visual Acuity | 2010 |
Intravitreal bevacizumab injection for central serous chorioretinopathy.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Central Serous Chorioretinopathy; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Injections; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
High-resolution imaging of resolved central serous chorioretinopathy using adaptive optics scanning laser ophthalmoscopy.
Topics: Adult; Aged; Aged, 80 and over; Cell Count; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Laser Coagulation; Male; Middle Aged; Ophthalmoscopy; Photochemotherapy; Retinal Cone Photoreceptor Cells; Tomography, Optical Coherence; Vision Disorders; Visual Acuity | 2010 |
Intravitreal bevacizumab injection for central serous chorioretinopathy.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Central Serous Chorioretinopathy; Coloring Agents; Fluorescein Angiography; Humans; Indocyanine Green; Injections; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body | 2010 |
Retinal sensitivity after photodynamic therapy with half-dose verteporfin for chronic central serous chorioretinopathy: short-term results.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Chronic Disease; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Retina; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity; Visual Field Tests; Visual Fields | 2011 |
Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy.
Topics: Adult; Central Serous Chorioretinopathy; Choroid; Chronic Disease; Coloring Agents; Eyeglasses; Female; Fovea Centralis; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Recurrence; Regional Blood Flow; Retina; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity | 2011 |
The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Prospective Studies; Recurrence; Retreatment; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Microperimetric changes after photodynamic therapy for central serous chorioretinopathy.
Topics: Adult; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retina; Tomography, Optical Coherence; Verteporfin; Visual Acuity; Visual Field Tests; Visual Fields | 2011 |
Diagnostic and therapeutic challenges.
Topics: Acetazolamide; Central Serous Chorioretinopathy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Middle Aged; Prednisone; Retinal Detachment; Subretinal Fluid; Tomography, Optical Coherence; Vision Disorders; Visual Acuity; Vitelliform Macular Dystrophy | 2011 |
Morphologic differences, according to etiology, in pigment epithelial detachments by means of en face optical coherence tomography.
Topics: Adult; Aged; Aged, 80 and over; Central Serous Chorioretinopathy; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Male; Middle Aged; Retinal Detachment; Retinal Pigment Epithelium; Tomography, Optical Coherence | 2011 |
Bilateral central serous retinopathy following laser in situ keratomileusis for myopia.
Topics: Central Serous Chorioretinopathy; Coloring Agents; Corneal Topography; Fluorescein Angiography; Functional Laterality; Humans; Indocyanine Green; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Middle Aged; Myopia; Photochemotherapy; Postoperative Complications; Tomography, Optical Coherence; Visual Acuity | 2011 |
Concentration of cytokines in the aqueous humor of patients with central serous chorioretinopathy.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Aqueous Humor; Bevacizumab; Central Serous Chorioretinopathy; Cytokines; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Immunoassay; Indocyanine Green; Male; Middle Aged; Platelet-Derived Growth Factor; Prospective Studies; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
Topics: Capillary Permeability; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Fovea Centralis; Humans; Indocyanine Green; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2011 |
The expanded spectrum of focal choroidal excavation.
Topics: Adult; Central Serous Chorioretinopathy; Choroid Diseases; Coloring Agents; Dilatation, Pathologic; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Photography; Retrospective Studies; Sclera; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2011 |
One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
Topics: Aged; Central Serous Chorioretinopathy; Choroid; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2011 |
Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
Topics: Adult; Central Serous Chorioretinopathy; Chronic Disease; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Recurrence; Retinal Detachment; Retinal Photoreceptor Cell Inner Segment; Retinal Photoreceptor Cell Outer Segment; Retinal Pigment Epithelium; Tomography, Optical Coherence; Verteporfin; Visual Acuity | 2011 |
Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2012 |
Near-infrared autofluorescence and indocyanine green angiography in central serous chorioretinopathy.
Topics: Adult; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Ophthalmoscopy | 2012 |
Indocyanine green angiography in chronic central serous chorioretinopathy.
Topics: Aged; Angiography; Central Serous Chorioretinopathy; Female; Humans; Indocyanine Green; Male; Middle Aged; Tomography, Optical Coherence; Tonometry, Ocular; Visual Acuity | 2012 |
Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. 2003.
Topics: Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Fluorescein Angiography; History, 21st Century; Humans; Indocyanine Green; Photochemotherapy | 2012 |
Retro-mode Imaging for retinal pigment epithelium alterations in central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Coloring Agents; Diagnostic Imaging; Female; Fluorescein Angiography; Humans; Indocyanine Green; Lasers; Male; Middle Aged; Ophthalmoscopes; Retinal Pigment Epithelium; Retrospective Studies; Subretinal Fluid; Tomography, Optical Coherence | 2012 |
Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Choroid; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Imaging, Three-Dimensional; Indocyanine Green; Macula Lutea; Male; Middle Aged; Organ Size; Prospective Studies; Tomography, Optical Coherence; Visual Acuity | 2012 |
Time-periodic characteristics in the morphology of idiopathic central serous chorioretinopathy evaluated by volume scan using spectral-domain optical coherence tomography.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Coloring Agents; Cross-Sectional Studies; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Recurrence; Retina; Retinal Pigment Epithelium; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Visual Acuity | 2012 |
Atypical vitelliform macular dystrophy misdiagnosed as chronic central serous chorioretinopathy: case reports.
Topics: Adult; Central Serous Chorioretinopathy; Chronic Disease; Diagnostic Errors; Fluorescein Angiography; Fluorescence; Humans; Indocyanine Green; Male; Middle Aged; Tomography, Optical Coherence; Vitelliform Macular Dystrophy | 2012 |
Reduced-fluence photodynamic therapy for subfoveal serous pigment epithelial detachment with choroidal vascular hyperpermeability.
Topics: Adult; Aged; Capillary Permeability; Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Humans; Indocyanine Green; Laser Therapy; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Detachment; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2012 |
Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration.
Topics: Aged; Central Serous Chorioretinopathy; Coloring Agents; Diagnosis, Differential; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Retinal Neovascularization; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Wet Macular Degeneration | 2012 |
The effect of photodynamic therapy on macular sensitivity in eyes with acute central serous chorioretinopathy.
Topics: Acute Disease; Adult; Aged; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retina; Retrospective Studies; Verteporfin; Visual Acuity; Visual Field Tests; Visual Fields | 2013 |
Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Capillary Permeability; Central Serous Chorioretinopathy; Choroid; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Male; Middle Aged; Polyps; Ranibizumab; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2013 |
Early changes in foveal thickness in eyes with central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Fovea Centralis; Humans; Indocyanine Green; Male; Middle Aged; Retinal Detachment; Retrospective Studies; Subretinal Fluid; Time Factors; Tomography, Optical Coherence; Visual Acuity | 2013 |
Central serous chorioretinopathy in young adults.
Topics: Adolescent; Central Serous Chorioretinopathy; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity; Young Adult | 2012 |
Morphologic changes in acute central serous chorioretinopathy using spectral domain optical coherence tomography.
Topics: Acute Disease; Adult; Central Serous Chorioretinopathy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Microscopy, Confocal; Middle Aged; Retrospective Studies; Tomography, Optical Coherence | 2012 |
Choroidal thickness in central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Choroid; Coloring Agents; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intraocular Pressure; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Visual Acuity | 2013 |
Photodynamic therapy for chronic central serous chorioretinopathy: a 4-year follow-up study.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retina; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2013 |
Circumscribed choroidal haemangioma mimicking chronic central serous chorioretinopathy.
Topics: Central Serous Chorioretinopathy; Choroid Neoplasms; Diagnostic Errors; Fluorescein Angiography; Hemangioma; Humans; Indocyanine Green; Macula Lutea; Male; Middle Aged; Neoplasms, Multiple Primary; Photochemotherapy; Porphyrins; Retinal Pigment Epithelium; Subretinal Fluid; Tomography, Optical Coherence; Ultrasonography; Verteporfin | 2013 |
[Analysis of fundus fluorescein angiography, indocyanine green angiography and choroidal thickness in central serous chorioretinopathy].
Topics: Adult; Aged; Case-Control Studies; Central Serous Chorioretinopathy; Choroid; Female; Fluorescein Angiography; Humans; Indocyanine Green; Male; Middle Aged; Radiography; Tomography, Optical Coherence | 2012 |
Half-fluence photodynamic therapy in chronic central serous chorioretinopathy.
Topics: Adult; Aged; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retina; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Verteporfin; Visual Acuity | 2013 |
Long-term chorioretinal changes after photodynamic therapy for chronic central serous chorioretinopathy.
Topics: Adult; Central Serous Chorioretinopathy; Chronic Disease; Coloring Agents; Disease Progression; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Indocyanine Green; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retina; Retinal Photoreceptor Cell Inner Segment; Retinal Photoreceptor Cell Outer Segment; Retrospective Studies; Tomography, Optical Coherence; Verteporfin; Visual Acuity; Visual Field Tests; Visual Fields | 2013 |